A comparative study on the ototoxicity of dibekacin and tobramycin administered by intravenous infusion.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000633:toxicity*; D003051:Cochlea / Q000187:drug effects; D003982:Dibekacin / Q000633:toxicity*; D004423:Ear / Q000187:drug effects*; D004558:Electric Stimulation; D006198:Hair Cells, Auditory / Q000473:pathology; D007263:Infusions, Parenteral; D007612:Kanamycin / Q000031:analogs & derivatives*; D007674:Kidney Diseases / Q000139:chemically induced / Q000473:pathology; D011817:Rabbits; D014031:Tobramycin / Q000633:toxicity*; D000159:Vestibulocochlear Nerve / Q000187:drug effects / Q000502:physiology
D000900:Anti-Bacterial Agents; D003982:Dibekacin; D007612:Kanamycin; D014031:Tobramycin